BackgroundImmunotherapy combined with chemotherapy has improved outcomes in advanced gastric cancer (GC), but reliable biomarkers to predict clinical benefit remain limited. Metabolomics provides a co
(A) MWCNTs extracted by means of KOH digestion from exposed-animals tissues. (B-D) MWCNTs crude powder (used as control) raw (B), after sonication (C) and after KOH treatment (D). Bars in A-D: 500nm.
